Categories
Health

Pfizer says it’s growing a Covid booster shot to focus on the extremely transmissible delta variant

Pfizer and BioNTech announced Thursday that they are developing a Covid-19 booster vaccine that will target the Delta variant amid concerns about the highly communicable strain that is already the predominant form of the disease in the United States.

The companies said that while they believe a third vaccination of their current two-dose vaccine has the potential to maintain the “highest level of protection” against all currently known variants, including Delta, they are “vigilant” and are developing an updated version of the Vaccine.

“As evidenced by real evidence from the Israeli Ministry of Health, the effectiveness of the vaccine has declined six months after vaccination, while at the same time the Delta variant is becoming the dominant variant in the country,” the companies said in a written statement.

“These results are consistent with an ongoing analysis of the companies’ Phase 3 study,” they said. “This is why we have said, and continue to believe, that all of the data we have, it is likely that a third dose may be required within 6 to 12 months of full vaccination.”

Clinical trials could begin as early as August, subject to regulatory approvals, the companies said.

The announcement comes on the same day the Olympic Games organizers said they would be banning all viewers from the Games this year after Japan declared a state of emergency designed to stem a wave of new Covid-19 infections that are partly due to the Delta variant is due.

Delta is estimated by the World Health Organization to be about 55% more transmissible than Alpha, the variant first found in the UK that once dominated the US, didn’t do as well at protecting against mild illnesses and the spread of the disease to others, scientists say.

On Monday, Israeli officials reported a decrease in the effectiveness of the Pfizer BioNTech vaccine in preventing infections and symptomatic diseases, but said it remained highly effective in preventing serious diseases.

In the US, health officials are urging all eligible Americans to get vaccinated as soon as possible, especially before the fall season when Delta is expected to lead to a further surge in new coronavirus cases, especially in places with the lowest vaccination rates.

There are about 1,000 counties in the U.S. with a Covid vaccination rate of less than 30%, mostly located in the Southeast and Midwest, said CDC Director Dr. Rochelle Walensky recently. In these areas, the authority already sees increasing infection rates due to the further spread of the delta variant.

Pfizer and BioNtech executives have repeatedly said that people will likely need a booster vaccination or a third dose within 12 months of full vaccination, as they expect vaccine-induced immunity to wear off over time. They also said that people are likely to have to take extra shots every year.

Pfizer and BioNTech are developing booster vaccines and are expected to apply for US approval for a third dose of their vaccine shortly.

Categories
Health

Boris Johnson says variant from India extra transmissible

British Prime Minister Boris Johnson speaks during a televised press conference at 10 Downing Street on February 22, 2021 in London, England.

Leon Neal | Getty Images News | Getty Images

LONDON – British Prime Minister Boris Johnson warned on Friday that the variant of the coronavirus, first discovered in India, has the potential to prevent the easing easing currently underway in the country.

The UK is now set to accelerate the second dose of vaccine for those over 50 and clinically at risk due to concerns about the Indian variant.

At a news conference on Friday, Johnson said the variant was more transmissible than other strains but warned it was not clear by how much. The English chief physician Chris Whitty speaks alongside Johnson, added that there is “confidence” that it is “more transferable” than the variants already circulating in the country.

Whitty said, “Earlier this week we said we thought it was as transferable as B.1.1.7 and possibly even more. There is now confidence … that this variation is more transferable than B.1.1.7 . “

The B.1.1.7 variant, known as the UK or Kent strain, has an unusually high number of mutations and is associated with more efficient and faster transmission of the coronavirus. British scientists first discovered this mutation in September last year, and it was the dominant strain in the United States by April

Johnson added that there is currently no evidence that the variant would dodge the vaccines that are being used across the country.

“But I have to measure myself with you, this new variant could seriously disrupt our progress,” said Johnson.

“And I have to emphasize that we will do everything we can to protect the public.”

Data on the new variant, released Thursday by Public Health England, showed the number of cases across the UK had increased from 520 last week to 1,313 this week, with most cases in North West England and some clusters concentrated in London.

The introduction of vaccines in the UK was one of the fastest in the world. Almost 70% of the adult population received at least one shot. Vaccines are available to anyone over the age of 38, but the government has said they could be made available to younger people in multi-generational households.

The next phase of England’s exit from the lockdown is slated for Monday, when the conviviality, hospitality and indoor entertainment will resume.

– CNBC’s Elliot Smith contributed to this article.

Categories
Health

Coronavirus Variant Is Certainly Extra Transmissible, New Research Suggests

A team of British scientists published a worrying study on Wednesday of the new variant of coronavirus sweeping the UK. They warned that the variant was so contagious that new control measures, including closing schools and universities, may be required. Even that might not be enough, they said, saying, “It may be necessary to speed up the introduction of vaccines significantly.”

Nicholas Davies, lead author of the study, said the model should also serve as a warning to other countries where the variant may have already spread.

“The preliminary results are pretty convincing that faster vaccination is going to be a really important matter for any country dealing with this or similar variants,” said Dr. Davies, an epidemiologist at the London School of Hygiene and Tropical Medicine, in an interview.

The study, published by the Center for Mathematical Modeling of Infectious Diseases at the London School of Hygiene and Tropical Medicine, has not yet been reviewed by a scientific journal. The study compares a number of models as predictors of data on infection, hospital stays, and other variables. Other researchers are testing the variant in laboratory experiments to see if it is biologically different.

The study found no evidence that the variant was more deadly than others. However, the researchers estimated that it was 56 percent more contagious. On Monday the British government released an initial estimate of 70 percent.

Bill Hanage, an epidemiologist at Harvard TH Chan School of Public Health who was not involved in the study, said it provided a compelling explanation of the variant’s past and possible future.

“The overall message is solid and in line with what we’ve seen from other sources of information,” he said in an interview. “Is that important? Yes. Is there any evidence of increased transmission? Yes. Will that have an impact in the next few months? Yes. These are all pretty solid. “

The variant, which British researchers became aware of earlier this month, has spread rapidly in London and eastern England. It contains 23 mutations, some of which can be more contagious.

Dr. Davies and colleagues found more evidence that the variant actually spreads faster than others. For example, they ruled out the possibility that it was becoming more common in some regions of the UK because people in those places were more moving and more likely to come into contact with one another. Data recorded by Google showing the movements of individual cell phone users over time showed no such difference.

The researchers built various mathematical models and tested each one as an explanation for the spread of the variant. They analyzed which model of spread best predicted the number of actually confirmed new cases, as well as hospitalizations and deaths.

The researchers concluded that the variant can, on average, spread to more people than other variants. Dr. Davies warned that their estimate of 56 percent more contagious is still crude as they are still collecting data on the recent spread of the variant. “I think if we get more of that corner we will be safer,” he said.

Despite the data he and his colleagues have so far, he is confident that the new variant must be taken very seriously. “I think that given all the evidence, it is a strong case,” he said.

Updated

Apr. 27, 2020, 6:19 am ET

Dr. Davies and his colleagues then predicted what the new variant would do over the next six months and built models that took different constraints into account. Without a broader roll-out of vaccines, they warned, “Cases, hospitalizations, ICU admissions and deaths in 2021 could exceed those in 2020.”

Closing schools through February could buy the UK some time, the researchers noted, but lifting those additional restrictions would then result in a significant recovery in cases.

Dr. Davies and his colleagues also considered the protection vaccines offer. Vaccine experts are confident that coronavirus vaccines can block the new variant, although this needs to be confirmed by laboratory experiments that are currently being carried out.

To study the effects of the current vaccination rate, the researchers created a model that vaccinated 200,000 people each week. This pace was too slow to have much of an impact on the outbreak. “That kind of pace wouldn’t really help loosen control measures,” said Dr. Davies.

When they increased the vaccinations to 2 million a week, they saw a decrease in the peak load for intensive care units. Whether the UK can increase vaccinations by a factor of 10 is unknown.

As of Tuesday, the variant had not been identified in the United States, according to the Centers for Disease Control and Prevention. “Given the low proportion of US infections sequenced, the variant could already be in the US without being detected,” they warned.

The United States is vaccinating its citizens more slowly than expected. This could potentially become a problem if the variant spreads in the UK to the US.

“You need to be able to remove any obstacles to transmission as quickly as possible,” said Dr. Hanage.

Dr. Davies warned that the model he and his colleagues analyzed, like any model, was based on a number of assumptions, some of which could prove to be incorrect. For example, the rate at which infected people die from Covid-19 may continue to decline as doctors improve care for hospital patients. There are still uncertainties as to whether and by how much the new variant is more contagious in children.

They also didn’t consider other tools to stop the spread of the variant, such as an aggressive program to test people and isolate those infected. “That’s a limitation of the paper,” said Dr. Davies. Researchers are now starting to analyze new possibilities like this.

Nevertheless, Dr. Davies and his colleagues in the conclusion of their study: “There is an urgent need to examine which new approaches may be necessary in order to sufficiently reduce the ongoing transmission of SARS-CoV-2.”

Commenting on the new estimates, Alessandro Vespignani, director of the Network Science Institute at Northeastern University in Boston, who was not involved in the study, said: “Unfortunately, this is another turn in the plot.”

“While we were all excited about the vaccine,” he added, “there is a potential for a change in the epidemiological context that will make our next few months much more complex and dangerous to navigate.” Evidence is mounting that the variant is more transmissible, and this implies that even greater efforts are likely to be needed to keep its spread under control. “

Dr. Hanage warned that the model had some flaws. The researchers assumed that anyone under the age of 20 had a 50 percent chance of spreading the disease. Although this might be true for younger children, Dr. Hanage, it’s not for teenagers. “That’s the weakest part of their model,” he said.

Nevertheless, the study offers an important insight into the possible future of the country. “It’s not a forecast, it’s not a prediction, it doesn’t mean this is going to happen,” he said. “They say that if you don’t take it seriously, it can happen very easily.”

Benjamin Mueller contributed to the reporting.

[Like the Science Times page on Facebook. | Sign up for the Science Times newsletter.]